StockData
Exagen Inc. logo

Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.76−0.01 (-0.27%)

Close on Nov 17, 2026Market cap $91.09MP/E –Yield –

Exagen price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Exagen's price to book ratio was 10.0× on Nov 11, 2026, against 9.8× a year earlier. Over the last 5 years it ranged from 0.6× to 23.5×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.0×+2.4
2025Dec 31, 20257.5×+2.0
2024Dec 31, 20245.6×+4.4
2023Dec 29, 20231.2×+0.5
2022Dec 30, 20220.7×−1.4
2021Dec 31, 20212.1×−1.7
2020Dec 31, 20203.8×−1.7
2019Dec 31, 20195.4×–

More Exagen figures

See a number that looks wrong?